MEDINBIO: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MEDINBIO
Largest movements
- Cash +€223,087
up €223,087 (+70.3%), from €317,176 to €540,264
mainly Current investments (+€150,000) and Trade debts (+€111,484)
- Financial fixed assets -€175,000
down €175,000 (-83.0%), from €210,955 to €35,955
- Current investments -€150,000
down €150,000 (-100%), from €150,000 to €0
- Stocks and contracts -€76,162
down €76,162 (-16.3%), from €467,829 to €391,667
- Intangible fixed assets +€66,986
up €66,986 (+492%), from €13,615 to €80,601
- Profit (loss) carried forward -€170,556
down €170,556 (-32.5%), from €525,035 to €354,479
- Trade debts +€111,484
up €111,484 (+76.4%), from €145,924 to €257,408
- Other debts -€47,920
down €47,920 (-96.6%), from €49,621 to €1,701
- Debts after one year -€35,714
down €35,714 (-21.1%), from €169,643 to €133,929
- Gross operating margin -€234,880
down €234,880 (-33.9%), from €693,874 to €458,993
- Financial charges +€175,944
up €175,944 (+1,030%), from €17,080 to €193,025
of which Non-recurring financial charges: +€174,999
- Taxes -€52,701
down €52,701 (-96.0%), from €54,922 to €2,222
- Write-downs -€33,489
down €33,489 (-100%), from €33,489 to €0
- Staff costs +€11,788
up €11,788 (+3.4%), from €342,222 to €354,010
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €1,641,882 | €1,499,759 | -€142,123 | -8.7% |
| Fixed assets | 21/28 | €258,239 | €137,477 | -€120,762 | -46.8% |
| Intangible fixed assets | 21 | €13,615 | €80,601 | +€66,986 | +492% |
| Tangible fixed assets | 22/27 | €33,669 | €20,922 | -€12,748 | -37.9% |
| Plant, machinery and equipment | 23 | €12,197 | €7,877 | -€4,319 | -35.4% |
| Furniture and vehicles | 24 | €18,968 | €9,817 | -€9,151 | -48.2% |
| Other tangible fixed assets | 26 | €2,504 | €3,227 | +€723 | +28.9% |
| Financial fixed assets | 28 | €210,955 | €35,955 | -€175,000 | -83.0% |
| Current assets | 29/58 | €1,383,643 | €1,362,282 | -€21,361 | -1.5% |
| Stocks and contracts in progress | 3 | €467,829 | €391,667 | -€76,162 | -16.3% |
| Stocks | 30/36 | €467,829 | €391,667 | -€76,162 | -16.3% |
| Amounts receivable within one year | 40/41 | €437,885 | €409,365 | -€28,520 | -6.5% |
| Trade receivables | 40 | €298,395 | €262,594 | -€35,801 | -12.0% |
| Other amounts receivable | 41 | €139,490 | €146,771 | +€7,281 | +5.2% |
| Current investments | 50/53 | €150,000 | €0 | -€150,000 | -100% |
| Cash at bank and in hand | 54/58 | €317,176 | €540,264 | +€223,087 | +70.3% |
| Deferred charges and accrued income | 490/1 | €10,753 | €20,987 | +€10,234 | +95.2% |
| Total equity and liabilities | 10/49 | €1,641,882 | €1,499,759 | -€142,123 | -8.7% |
| Equity | 10/15 | €1,175,035 | €1,004,479 | -€170,556 | -14.5% |
| Contributions | 10/11 | €650,000 | €650,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €525,035 | €354,479 | -€170,556 | -32.5% |
| Amounts payable | 17/49 | €466,847 | €495,280 | +€28,433 | +6.1% |
| Amounts payable after more than one year | 17 | €169,643 | €133,929 | -€35,714 | -21.1% |
| Financial debts | 170/4 | €169,643 | €133,929 | -€35,714 | -21.1% |
| Amounts payable within one year | 42/48 | €286,744 | €351,146 | +€64,403 | +22.5% |
| Current portion of amounts payable after more than one year | 42 | €39,477 | €35,714 | -€3,762 | -9.5% |
| Trade debts | 44 | €145,924 | €257,408 | +€111,484 | +76.4% |
| Suppliers | 440/4 | €145,924 | €257,408 | +€111,484 | +76.4% |
| Taxes, remuneration and social security | 45 | €51,722 | €56,323 | +€4,601 | +8.9% |
| Taxes | 450/3 | €1,959 | €13,464 | +€11,505 | +587% |
| Remuneration and social security | 454/9 | €49,763 | €42,859 | -€6,904 | -13.9% |
| Other amounts payable | 47/48 | €49,621 | €1,701 | -€47,920 | -96.6% |
| Accrued charges and deferred income | 492/3 | €10,460 | €10,205 | -€255 | -2.4% |
| Non-recurring operating income | 76A | - | €11,273 | +€11,273 | |
| Remuneration, social security and pensions | 62 | €342,222 | €354,010 | +€11,788 | +3.4% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €33,222 | €31,719 | -€1,504 | -4.5% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals) | 631/4 | €33,489 | €0 | -€33,489 | -100% |
| Other operating charges | 640/8 | €5,397 | €3,973 | -€1,423 | -26.4% |
| Non-recurring operating charges | 66A | - | €51,400 | +€51,400 | |
| Gross operating margin | 9900 | €693,874 | €458,993 | -€234,880 | -33.9% |
| Operating profit (loss) | 9901 | €279,543 | €17,892 | -€261,652 | -93.6% |
| Financial income | 75/76B | €15,062 | €6,798 | -€8,264 | -54.9% |
| Recurring financial income | 75 | €15,062 | €6,798 | -€8,264 | -54.9% |
| Financial charges | 65/66B | €17,080 | €193,025 | +€175,944 | +1,030% |
| Recurring financial charges | 65 | €17,080 | €18,026 | +€945 | +5.5% |
| Non-recurring financial charges | 66B | - | €174,999 | +€174,999 | |
| Profit (loss) for the period before taxes | 9903 | €277,525 | -€168,335 | -€445,860 | |
| Income taxes | 67/77 | €54,922 | €2,222 | -€52,701 | -96.0% |
| Profit (loss) for the period | 9904 | €222,603 | -€170,556 | -€393,159 | |
| Profit (loss) for the period to be appropriated | 9905 | €222,603 | -€170,556 | -€393,159 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 21 October 2026 via checked.be.